DAY ONE

Vein In Venice > DAY ONE

Vein in Venice 2026 - Day one

Scientific Session Workshop Break Special Session
 
Sala Perla - Lecture Hall
Sala Volpi - Workshop Room

09:00 Opening Ceremony

Speakers: L. Palombi, F. Martinelli, E. Mendoza, M. Whiteley, L. Kabnick, R. Rodriguez Carvajal

Session I

09:10–11:00 Chronic Venous Disease: we need to delve deeper!

  • New Perspectives on Micronised Purified Flavonoid Fraction (MPFF): from microvalves to clinical effectiveness
  • The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease
  • The Microbiota: does it play a role in CVD?
  • Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities
  • Chronic venous insufficiency in heart failure: exploring a reciprocal influence on cardiovascular health
  • What are the effects of Sulodexide on diabetes-induced disabilities?
  • Clinical evidence and rationale of Mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review
  • Cellular senescence at the saphenofemoral junction in different vein conditions
  • Low-dose direct oral anticoagulants for secondary prevention (Italian START2 Registry retrospective analysis)
  • Does Artificial Intelligence bring new insights in diagnosing phlebological diseases? — Systematic review

10:00–11:00 Non-Thermal Procedures — Recorded Cases

  • Non-rotational MOCA
  • Glue Occlusion
  • Rotational MOCA
  • Glue direct puncture for recurrent varicose veins
  • ScleroSafe Device

11:00–11:30 Coffee Break

Session II

11:30–13:30 2026 ERA in the Surgical Management of Deep Vein System and Pelvic Veins Disease

  • Part 1 — Evidence: Endovascular treatment of DVT: evidence & controversies
  • Current evidence in deep chronic venous disease: gaps and future directions
  • Last-generation venous stents: evidence, indications and patient selection
  • Current management of PE: indications and treatment options
  • Part 2 — Technical: treating pelvic vein insufficiency (compression vs primary incompetence)
  • Recurrences in pelvic vein insufficiency: approaches
  • Inferior Vena Cava occlusion: tips & tricks
  • Multiple Vein Compression Syndrome: diagnostic and therapeutic options

11:30–12:30 Vein in Venice & Vein and Lymphatic University

  • Lecture / institutional session

13:30–14:00 Lunch Break

Session III

14:00–15:30 Sclerotherapy: let's try to standardize the treatment!

  • Master Lecture: The Role of Sclerotherapy in Venous Disease
  • GSV and SSV treatment: literature & guideline recommendations on diameters and volumes
  • Efficacy of Ultrasound-Guided Foam Sclerotherapy (UGFS) in Venous Leg Ulcer
  • Automated device for reticular and spider veins — Pro side
  • Automated device for reticular and spider veins — Contra side
  • Hemorrhoidal pathology: when to treat with sclerotherapy
  • Post-treatment directions: is there clarity?
  • Sclerotherapy with tourniquet: advantages

14:00–15:00 Endovascular Management of DVT — Recorded Cases

  • TEP
  • ILIO-CAVA
  • ILIO-FEMORAL
  • IN-STENT Thrombosis
  • VTOS
Session IV

15:45–17:30 Thermal Ablation for Varicose Vein Treatment

  • Results from TOTEM trial
  • Laser Flush ligation: indications and results
  • Comparative EVLA: 1940 nm vs 1470 nm
  • Late pulmonary embolism after endovenous thermal ablation
  • Comparing venous wall effects: VELEX vs EVLA vs foam (animal model)
  • Third-generation ClosureFast RFA — early outcomes
  • Complications of endovenous thermal ablation
  • Microwave ablation of saphenous vein insufficiency: efficacy, safety, QoL
  • To treat or not to treat competent AASV alongside refluxive GSV?
  • Refined delivery of tumescent anesthesia in endovenous laser ablation using a blunt multi-side-hole liposuction cannula

16:00–17:00 Sclerotherapy — Recorded Cases

  • Recorded cases presentation and discussion
Session V

17:45–19:00 Non-Thermal Ablation & HIFU

  • Five-year follow-up of EVLA vs MOCA (LAMA trial)
  • Real-world safety & efficiency of cyanoacrylate glue
  • Vein diameter, obesity and recanalization after MOCA
  • Systematic review of mechanochemical ablation (Flebogrif)
  • Contemporary management of SSV incompetence (FOVELASS results)
  • HIFU: patient selection criteria
  • HIFU-pain study: anaesthesia protocols
  • New devices in the non-thermal family